Guidelines for Idiopathic Pulmonary Fibrosis (IPF):
Assistance in writing and publication of the good clinical practice guidelines in IPF as per HAS’s methodology (HAS: Haute Autorité de Santé)

Objective:

Fulfil physicians’ expectations re introduction of new therapies
As per the request of National Reference Centre of rare lung diseases (Respifil sub-group, Orphalung network):
Establish a consensus among French experts on the guidelines for the management of the IPF
Publish these guidelines in a renowned medical journal

1st edition : 2012-2013 (12 month). 2nd edition : 2016-2017 (9 month). 3rd edition : 2020-2021 (in progress).

Creation of the coordination, writing and review groups (HAS’s methodology for national guidelines for the management and treatment)
Writing of the initial draft (V0) with the coordination group
Writing of the first version (V1) with the writing group (consensus methodology which allows to validate, invalidate, amend every recommendation)
Finalisation of the French version further to a submission to the review group, final amendments and proofreading by the coordination group.

Publications of the Good practice Guidelines which will be a French reference for the management and treatment of this pathology